The current, fourth quarter isn't going to get any better. Despite launching its new Efficeon processor on Tuesday, Transmeta reckons its sales could halve again at worst - at best, they'll stay the same - with a loss of around 15-17 cents a share. That's excluding $3 million worth of non-cash amortization and deferred compensation charges.
Read more: [URL=http://www.theregister.co.uk/content/3/33426.html]The Register[/URL].
Downloads and Drivers
From the Forums
Subscribe to TechSpot
Get free exclusive content, learn about new features and breaking tech news.